Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP166340.RAHXczcItjfoXBfNjp0_wMVnSFTf_l-QAF5ooGHZ3SRvc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP166340.RAHXczcItjfoXBfNjp0_wMVnSFTf_l-QAF5ooGHZ3SRvc130_assertion type Assertion NP166340.RAHXczcItjfoXBfNjp0_wMVnSFTf_l-QAF5ooGHZ3SRvc130_head.
- NP166340.RAHXczcItjfoXBfNjp0_wMVnSFTf_l-QAF5ooGHZ3SRvc130_assertion description "[Deguelin inhibited survivin expression in tuberous sclerosis complex 2 (TSC2) wild-type mouse embryonic fibroblasts (MEF) but not in TSC2-knockout MEFs in which mammalian target of rapamycin (mTOR) is constitutively active.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP166340.RAHXczcItjfoXBfNjp0_wMVnSFTf_l-QAF5ooGHZ3SRvc130_provenance.
- NP166340.RAHXczcItjfoXBfNjp0_wMVnSFTf_l-QAF5ooGHZ3SRvc130_assertion evidence source_evidence_literature NP166340.RAHXczcItjfoXBfNjp0_wMVnSFTf_l-QAF5ooGHZ3SRvc130_provenance.
- NP166340.RAHXczcItjfoXBfNjp0_wMVnSFTf_l-QAF5ooGHZ3SRvc130_assertion SIO_000772 18089792 NP166340.RAHXczcItjfoXBfNjp0_wMVnSFTf_l-QAF5ooGHZ3SRvc130_provenance.
- NP166340.RAHXczcItjfoXBfNjp0_wMVnSFTf_l-QAF5ooGHZ3SRvc130_assertion wasDerivedFrom befree-20140225 NP166340.RAHXczcItjfoXBfNjp0_wMVnSFTf_l-QAF5ooGHZ3SRvc130_provenance.
- NP166340.RAHXczcItjfoXBfNjp0_wMVnSFTf_l-QAF5ooGHZ3SRvc130_assertion wasGeneratedBy ECO_0000203 NP166340.RAHXczcItjfoXBfNjp0_wMVnSFTf_l-QAF5ooGHZ3SRvc130_provenance.